Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.
Yokokawa T, Boucherat O, Martineau S, Lemay SE, Breuils-Bonnet S, Krishna V, Kalyana-Sundaram S, Jeyaseelan J, Potus F, Bonnet S, Provencher S. Yokokawa T, et al. Among authors: kalyana sundaram s. J Am Heart Assoc. 2024 Jun 18;13(12):e032888. doi: 10.1161/JAHA.123.032888. Epub 2024 Jun 14. J Am Heart Assoc. 2024. PMID: 38874078 Free PMC article.
Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
El Kabbout R, Azhar N, Breuils-Bonnet S, Martineau S, Krishna V, Kalyana-Sundaram S, Boucherat O, Provencher S, Bonnet S, Potus F. El Kabbout R, et al. Among authors: kalyana sundaram s. Am J Respir Cell Mol Biol. 2024 Feb;70(2):140-143. doi: 10.1165/rcmb.2023-0335LE. Am J Respir Cell Mol Biol. 2024. PMID: 38299796 No abstract available.
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension.
Boucherat O, Yokokawa T, Krishna V, Kalyana-Sundaram S, Martineau S, Breuils-Bonnet S, Azhar N, Bonilla F, Gutstein D, Potus F, Lawrie A, Jeyaseelan J, Provencher S, Bonnet S. Boucherat O, et al. Among authors: kalyana sundaram s. Nat Cardiovasc Res. 2022 Aug;1(8):748-760. doi: 10.1038/s44161-022-00113-w. Epub 2022 Aug 11. Nat Cardiovasc Res. 2022. PMID: 39196085
Pan AMPK Activation Protects Tubules in Rat Ischemic Acute Kidney Injury.
Frikke-Schmidt H, Albarazanji K, Qi J, Frederick D, Steffen J, Kalyana-Sundaram S, Meng R, Devine ZH, Chen T, Li Q, Du F, Ho G, Liu J, Riley R, Gonzalez-Villalobos RA, Camacho RC, Nawrocki AR, Pryor M, Lee M, Wong V, Matico R, Diaz E, Krosky D, Wall M, Gao E, Shah AA, Leonard J, Erion M, Pocai A, Player MR. Frikke-Schmidt H, et al. Among authors: kalyana sundaram s. J Pharmacol Exp Ther. 2024 Jun 7:JPET-AR-2024-002120. doi: 10.1124/jpet.124.002120. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 38849142 Free article.
Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.
Tolcher AW, Kurzrock R, Valero V, Gonzalez R, Heist RS, Tan AR, Means-Powell J, Werner TL, Becerra C, Wang C, Leonowens C, Kalyana-Sundaram S, Kleha JF, Gauvin J, D'Amelio AM Jr, Ellis C, Ibrahim N, Yan L. Tolcher AW, et al. Among authors: kalyana sundaram s. Cancer Chemother Pharmacol. 2020 Apr;85(4):673-683. doi: 10.1007/s00280-020-04038-8. Epub 2020 Feb 15. Cancer Chemother Pharmacol. 2020. PMID: 32062691 Free article. Clinical Trial.
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.
Mateo J, Ganji G, Lemech C, Burris HA, Han SW, Swales K, Decordova S, DeYoung MP, Smith DA, Kalyana-Sundaram S, Wu J, Motwani M, Kumar R, Tolson JM, Rha SY, Chung HC, Eder JP, Sharma S, Bang YJ, Infante JR, Yan L, de Bono JS, Arkenau HT. Mateo J, et al. Among authors: kalyana sundaram s. Clin Cancer Res. 2017 Oct 1;23(19):5981-5992. doi: 10.1158/1078-0432.CCR-17-0725. Epub 2017 Jun 23. Clin Cancer Res. 2017. PMID: 28645941 Clinical Trial.
44 results